ArticleInternational journal of molecular sciences2024

Glucosylceramide Synthase Inhibition in Combination with Aripiprazole Sensitizes Hepatocellular Cancer Cells to Sorafenib and Doxorubicin.

Richard Jennemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.